2024 Judson Daland Prize

The 2024 Judson Daland Prize in Patient-oriented Clinical Investigation is awarded to David C. Fajgenbaum in recognition of his work uncovering mechanisms and therapeutics across hyperinflammatory disorders and rare diseases. The award will be presented at the Society’s November Meeting.  The full citation will be posted at that time.

David C. Fajgenbaum, (MD, MBA, MSc) is Associate Professor of Medicine (Translational Medicine and Human Genetics), Founding Director, Center for Cytokine Storm Treatment & Laboratory (CSTL), Associate Director, Patient Impact, Orphan Disease Center, Raymond and Ruth Perelman School of Medicine, University of Pennsylvania.

The prize is named for Dr. Judson Daland, born in 1860, a prominent Philadelphia physician and outstanding figure in medical research who left the bulk of his estate to the Society to support research in clinical medicine. The prize recognizes outstanding achievement in clinical investigation, particularly patient-oriented research.  The $50,000 prize is presented every 3 to 5 years. In addition to the prize, a Judson Daland Fellowship is awarded annually using these funds.

The Daland selection committee members are Clyde F. Barker (chair), former President, American Philosophical Society, Donald Guthrie Professor, Department of Surgery, Hospital of the University of Pennsylvania; Lawrence H. Einhorn, Distinguished Professor, Livestrong Foundation Professor of Oncology, Professor of Medicine, Indiana University; and Ronald M. Fairman, The Clyde F. Barker - William Maul Measey Professor of Surgery Emeritus, Former Chief of Vascular Surgery and Endovascular Therapy, Vice-Chairman for Clinical Affairs, Department of Surgery, Hospital of the University of Pennsylvania.